Hypopharyngeal Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
Conditions: Hypopharyngeal Carcinoma; Immunotherapy; Chemotherapy Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: Capecitabine; Drug: Camrelizumab; Drug: Apatinib Sponsor: Eye & ENT Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials
